Cigna Corporation (C1IC34)
Sao Paulo Exchange · Brazil · prices in BRL · close of 6 Oct 2026
Key indicators
| Last close | BRL 56.82 |
|---|---|
| 52-week range | 50.40 – 66.20 |
| Return, 1 month / 3 months | −14.2% / −7.2% |
| Return, 1 year / 3 years | −11.9% / +17.3% |
| Trend | Below its 200-day average |
| RSI (14) | 36 |
| Volatility (1 year) | 41.2% |
| Worst drawdown (1 year) | -21.2% |
| Average daily value traded | 0.00M BRL |
| Dividend yield | 43.4% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Cigna Corporation is a health services company based in the United States. It provides medical, dental, disability and life insurance and related benefits to employers, individuals and other plan sponsors. Through its health services arm, it also offers pharmacy benefit management, specialty pharmacy and care management services. Its customers include large and small employers, government programmes and individuals, and it operates across markets in the United States and internationally.
Cigna Corporation is represented on the Sao Paulo Exchange in Brazil by a Brazilian depositary receipt (BDR) under the code C1IC34, with its price quoted in Brazilian reais (BRL). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Cigna Corporation (C1IC34) trades on the Sao Paulo Exchange in Brazil. It last closed at BRL 56.82 on 6 October 2026.
Its price-based Market X-Ray is 49 out of 100 (a weak price profile), ranking 801 of 1,454 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 11.9% and over the last three months it fell 7.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Sao Paulo Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 51 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -4.0% | ||
| From 52-week high | -14.2% | ||
| Momentum | 40 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -7.2% | ||
| 6-month return | -1.9% | ||
| 12-month return, skipping the last month | 2.6% | ||
| Stability (higher is calmer) | 61 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 41.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -21.2% | ||
| Liquidity | 16 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.00M BRL | ||
| Zero-volume days | 60.0% | ||
| Income | 84 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 43.4% | ||
| Years with dividends | 6 |
Strengths
- Income: Dividend is high and has been paid regularly.
Weak spots
- Momentum: Lagging most stocks on this exchange.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −3.9% |
|---|---|
| 1 month | −14.2% |
| 3 months | −7.2% |
| 6 months | −1.9% |
| 1 year | −11.9% |
| 3 years | +17.3% |
| 5 years | – |
Signals
| 50-day / 200-day average | 59.86 / 59.18 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.73 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 1 Jun 2026 | USD 7.8592 |
| 3 Mar 2026 | USD 8.3563 |
| 2 Dec 2025 | USD 8.4498 |
| 2 Sep 2025 | USD 8.1613 |
| 30 May 2025 | USD 8.4190 |
| 27 Feb 2025 | USD 8.7689 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Sao Paulo Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.